Environmental, modifiable risk factors for multiple sclerosis
3 Mar 2016 to 4 Mar 2016
Florence, Italy
Episode 69 with Dr. Alessandra Solari on information and decision tools for newly diagnosed patients
Links to articles and other resources mentioned in Episode 69
Clinical Research, Methods
Papers: 21 Feb 2016 - 28 Feb 2016
MS Research Roundup: 27 February 2016
FDA Fast-Tracks PPMS Drug Review; Molecular Target Runs Out of Air; Happy Accidents in the Lab; New Twist on Patient-Powered Research
Items of interest to multiple sclerosis researchers from around the Web...
Clinical Research, Drug Development, Laboratory Research, Meetings, People
Editors' Pick
Lessons From Fingolimod for PPMS
Lessons From Fingolimod for Primary Progressive Multiple Sclerosis
Fingolimod is ineffective for PPMS, but the phase 3 trial data may improve future studies
Even in failure, studies can be informative. Fingolimod, a disease-modifying treatment for relapsing-remitting multiple sclerosis, is...
Clinical Research, Drug Development, Meetings, Methods, People
Papers: 14 Feb 2016 - 21 Feb 2016
Papers: 14 Feb 2016 - 21 Feb 2016
Editors' Pick
Pages
